825 - Process Development and Manufacturing: ONE YEAR FROM VECTOR TO BEDSIDE: RAMPING UP A SUCCESSFUL IN-HOUSE CAR T-CELL MANUFACTURING PROGRAM USING A NOVEL TRI-SPECIFIC CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES.

Saved in:
Bibliographic Details
Title: 825 - Process Development and Manufacturing: ONE YEAR FROM VECTOR TO BEDSIDE: RAMPING UP A SUCCESSFUL IN-HOUSE CAR T-CELL MANUFACTURING PROGRAM USING A NOVEL TRI-SPECIFIC CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES.
Authors: Denlinger, N. (AUTHOR), Bradbury, H. (AUTHOR), Doseck, N. (AUTHOR), Williams, J. (AUTHOR), Brown, D. (AUTHOR), Skinner, R. (AUTHOR), Parris, K. (AUTHOR), Watts, M.C. (AUTHOR), Fisher, S. (AUTHOR), Stauffer, E. (AUTHOR), Dorado, J. (AUTHOR), Romanoff, N. (AUTHOR), Elsberry, D. (AUTHOR), Nelson, S. (AUTHOR), Howitz, M. (AUTHOR), Mead, T. (AUTHOR), Fenske, B. (AUTHOR), Nichols, S. (AUTHOR), Dash, P. (AUTHOR), Daneault, B. (AUTHOR)
Source: Cytotherapy (Elsevier Inc.). 2023 Supplement, Vol. 25 Issue 6, pS178-S179. 2p.
Database: Academic Search Ultimate
Description
ISSN:14653249
DOI:10.1016/S1465-3249(23)00472-3